Literature DB >> 29769650

Factors associated with pain during intravitreal injection of anti-vascular endothelial growth factor.

Ngoc Chau Isabelle Nguyen1, Filippo Fabro1, Aude Ambresin1, Sakina Ezziat1, Ciara Bergin1, Claudia Mazzocato2, Irmela Mantel3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29769650      PMCID: PMC6137149          DOI: 10.1038/s41433-018-0126-z

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  5 in total

1.  Anxiety levels and perceived pain intensity during intravitreal injections.

Authors:  Ori Segal; Yael Segal-Trivitz; Arie Y Nemet; Perri Cohen; Noa Geffen; Michael Mimouni
Journal:  Acta Ophthalmol       Date:  2015-07-28       Impact factor: 3.761

Review 2.  The Edmonton Symptom Assessment System: a 15-year retrospective review of validation studies (1991--2006).

Authors:  Cheryl Nekolaichuk; Sharon Watanabe; Crystal Beaumont
Journal:  Palliat Med       Date:  2008-03       Impact factor: 4.762

3.  Factors affecting patients' pain intensity during in office intravitreal injection procedure.

Authors:  Lana Rifkin; Shlomit Schaal
Journal:  Retina       Date:  2012-04       Impact factor: 4.256

4.  Psychoeducational intervention for patients with primary breast cancer and patient satisfaction with information: an exploratory analysis.

Authors:  Hitoshi Okamura; Sakiko Fukui; Yuriko Nagasaka; Makiko Koike; Yosuke Uchitomi
Journal:  Breast Cancer Res Treat       Date:  2003-08       Impact factor: 4.872

Review 5.  The Effects of Perioperative Music Interventions in Pediatric Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Marianne J E van der Heijden; Sadaf Oliai Araghi; Monique van Dijk; Johannes Jeekel; M G Myriam Hunink
Journal:  PLoS One       Date:  2015-08-06       Impact factor: 3.240

  5 in total
  1 in total

1.  [The Hamburg register for intravitreal injection therapies (QIVOM)].

Authors:  Christian Wolfram; Marc Schargus
Journal:  Ophthalmologe       Date:  2021-08-20       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.